The Influenza A Infections Market delivers a comprehensive suite of vaccines, antiviral therapies, monoclonal antibodies, and rapid molecular diagnostics designed to prevent, treat, and monitor seasonal and pandemic influenza A outbreaks. Vaccines—from traditional inactivated formulations to novel mRNA and recombinant protein platforms—offer advantages such as faster development...